You are here: Industry Insights > COVID-19

News List

Therapure Signs Manufacturing Deal with VBI Vaccines contractpharma
August 19, 2020
For biomanufacturing of coronavirus vaccine candidates as well as the aseptic fill of the drug product.
CARE consortium launched to fast-track discovery and development of medicines to treat COVID-19 expresspharma
August 19, 2020
The CARE consortium comprises 37 teams from academic and non-profit research institutions and pharma companies.
Thermo Fisher Scientific Continues to Expand Response to COVID-19 with the New and High-Throughput Automated Molecular Diagnostic Testing Solution expresspharma
August 19, 2020
Thermo Fisher Scientific, the world leader in serving science, recently introduced a new, automated real-time PCR solution that can analyze up to 6,000 COVID-19 samples in a single day.
AI accelerates drug repurposing to find potential COVID-19 therapies: GlobalData expresspharma
August 19, 2020
AI start-ups are helping pharma companies to digitally bridge the gap between thousands of repurposed drug molecules, clinical trials and final drug authorization.
Researchers design and test protein that may lead to COVID-19 therapeutic worldpharmanews
August 18, 2020
A novel receptor protein that binds to the SARS-CoV-2 virus and prevents it from entering cells may hold promise for treating COVID-19 and other coronavirus-related diseases, according to research published online Aug. 4 in the journal SCIENCE.
Blade Therapeutics updates enrolment progress for Covid-19 pneumonia study of BLD-2660 pharmaceutical-business-review
August 18, 2020
Blade Therapeutics announced that the Phase 2 clinical study of the company’s investigational therapeutic, BLD-2660, has enrolled half of the anticipated 120 coronavirus disease-19 (COVID-19) pneumonia patients.
Severely ill COVID-19 patients treated with convalescent plasma therapy europeanpharmaceuticalreview
August 18, 2020
Preliminary data from a study has shown that convalescent plasma therapy is safe and can combat COVID-19 in severely ill patients.
Doctors express concern over clearing NHS bottleneck pharmatimes
August 18, 2020
More than 70% of doctors feel it is unlikely that the NHS will resume a near-normal service by Autumn, a survey by the British Medical Association has revealed.
Kaiser Permanente Joins Late-Stage COVID-19 Vaccine Study americanpharmaceuticalreview
August 18, 2020
Kaiser Permanente has begun participating in a phase 3 clinical trial to test an investigational vaccine against SARS-CoV-2, the virus causing the current COVID-19 global pandemic.
Anixa, OntoChem Announce Identification of Additional Covid-19 Compounds americanpharmaceuticalreview
August 18, 2020
Anixa Biosciences announced that the company and its partner, OntoChem, have identified additional candidates through their in silico screening study.